Group 1 - The core viewpoint of the article highlights that Shenzhen Beilingsong Technology Co., Ltd. anticipates a net profit loss of 84 million to 105 million yuan for the fiscal year 2025, attributed to strategic adjustments and upgrades within the company [1] - The intelligent massage device industry is undergoing a critical period of high-quality transformation, facing intensified competition and evolving consumer demands towards efficacy and experience [1] - The company is focusing on a "Traditional Chinese Medicine × Technology" core strategy, emphasizing technological research and development, global expansion, and innovative business models to strengthen its development foundation [1] Group 2 - On the technology front, the company is concentrating on AI integration to build core competitiveness, upgrading its Traditional Chinese Medicine constitution identification model, and collaborating with major tech firms to enhance user experience and product precision [2] - The company is expanding its sales network in Southeast Asia and the Middle East, with plans to open 10 to 20 new stores in Southeast Asia by 2026, leveraging FDA-certified laser hair care technology to penetrate high-end markets in Europe and the U.S. [2] - The company is innovating its business model by launching the "Easy Moment" brand in 2025, which combines products with massage and moxibustion, and has already established 15 stores in various cities [2] Group 3 - The company is leveraging "Traditional Chinese Medicine × Technology" as a driving force, continuously broadening its growth boundaries and injecting momentum for long-term high-quality development [3]

Core Viewpoint - The company, Beiliang (688793.SH), anticipates a net profit attributable to shareholders of between -105 million to -84 million yuan for the fiscal year 2025, primarily due to strategic adjustments and upgrades in response to industry changes [1] Group 1: Industry Transition and Company Strategy - The smart massage device industry is undergoing a critical transition towards high-quality development, with intensified competition and evolving consumer demands focusing on efficacy and experience [1] - Beiliang's recent performance fluctuations reflect the objective realities of this industry transition, as the company actively adapts to both industry and operational changes [1] - The company is committed to its core strategy of "Traditional Chinese Medicine × Technology," focusing on technological research and development, global expansion, and innovative business models to enhance quality and efficiency [1] Group 2: AI Integration and Product Development - Beiliang is integrating AI as a core direction in product development, combining traditional wellness wisdom with modern technology [2] - The upgraded Chinese constitution identification model, along with AI analysis modules for tongue and pulse, will enable real-time constitution reports based on data from smart wearable devices [2] - Collaborations with tech giants like Alibaba Cloud and Baidu have led to the successful implementation of technologies that enhance user experience and massage precision [2] Group 3: Global Expansion and Brand Development - The company is advancing its globalization strategy by building a comprehensive sales network that integrates online and offline channels, focusing on Southeast Asia and the Middle East [3] - Plans for 2026 include opening 10-20 new offline stores in Southeast Asia, expanding successful models from Thailand to Indonesia and Vietnam [3] - Participation in international exhibitions, such as CES, showcases new products like the AIR3 smart massager and See7R eye massager, enhancing brand visibility and global market penetration [3] Group 4: Innovative Business Models and Growth Opportunities - Beiliang is launching the "Easy Moment" health management brand in 2025, combining self-developed technology products with manual massage and moxibustion therapy to create a hybrid business model [4] - Strategic partnerships with leading automotive companies like BYD and Chery are being formed to explore health solutions in the automotive sector, opening new growth channels [4] - The company is also addressing the aging population by developing products tailored for elderly users, with 13 products already included in a government initiative for smart home upgrades [4] Group 5: Long-term Development and Market Positioning - Through the integration of "Traditional Chinese Medicine × Technology" and diverse business models, Beiliang is continuously expanding its growth boundaries and strengthening its brand presence in both domestic and international markets [5]

Group 1 - The core theme of the 2026 CES is "AI deeply integrated into life," showcasing the global attention on health technology, with the company Beike (stock code: 688793) presenting its innovative "Technology × Traditional Chinese Medicine" achievements and global strategy [1] - Beike's globalization journey began with a strategic entry point, opening its first overseas store at Singapore Changi Airport in November 2024, establishing a high-standard brand image and testing operational logic for overseas markets [2] - The company has successfully implemented a replicable and efficient "brand store dealership model" in Thailand, which has led to profitability in Singapore and Malaysia, marking a sustainable development phase and providing stable cash flow for regional expansion [2] Group 2 - As of December 2025, Beike has established a global retail network with 125 standard direct stores, 77 global franchise stores, and over 500 other sales points, creating a comprehensive layout for brand experience and localized service [3] - The introduction of the "Relaxation Moment" sales-service integrated store model has become a second growth engine, combining sales of technology products with massage services, thus transforming the company's identity from a hardware provider to a personalized health solution service provider [3] - The CES participation is a significant milestone for Beike's globalization strategy, showcasing its product strength and brand ambition, with two flagship products addressing global consumer health pain points [4] Group 3 - The management expressed confidence in the company's global leadership ambitions, highlighting the successful validation of the "Technology × Traditional Chinese Medicine" concept in Southeast Asia and the systematic operational capabilities demonstrated through their expansion efforts [6] - Analysts note three core advantages of Beike's globalization path: clear strategy and strong execution, validated profitability models in Singapore and Malaysia, and significant differentiation through the "Technology × Traditional Chinese Medicine" concept [6] - The CES exhibition is expected to enhance the company's brand valuation as a global health technology brand, injecting strong momentum for long-term growth [6]

Core Insights - The article highlights the participation of Chinese health technology leader Beike (stock code: 688793) at the 2026 International Consumer Electronics Show (CES), showcasing its innovative products and global brand strategy [1][5]. Group 1: Product Launch and Innovation - Beike unveiled two flagship products, the AIR3 smart massage device and the See 7R eye care device, emphasizing the integration of AI technology in health solutions [4]. - The AIR3 smart massage device features a unique 5-second quick storage system and AI algorithms for personalized support, redefining travel comfort with its multifunctional capabilities [4]. - The See 7R eye massage device addresses dry eye syndrome through a three-step bionic therapy model, combining advanced technology with professional care techniques [4]. Group 2: Strategic Global Expansion - Beike's presence at CES is a significant step in its global strategy, following its successful market entry in Southeast Asia, including Singapore and Malaysia, where it achieved profitability [5]. - The company plans to implement a "one country, one policy" strategy for market expansion, focusing on both direct sales and franchise models in various Southeast Asian countries [5]. - The CES participation serves as a global validation of Beike's "technology × traditional Chinese medicine" concept and signals its commitment to international growth [5][6]. Group 3: Market Trends and Future Outlook - Industry analysis suggests that Beike is well-positioned to capitalize on the dual trends of global health consumption and AI technology proliferation, with a clear global strategy and proven profitability model [7]. - The CES showcase not only demonstrates Beike's product and technological capabilities but also aims to enhance its brand valuation in the global health technology market [7]. - The ongoing CES event, which runs until January 9, is attracting attention from global partners, media, and consumers, accelerating Beike's journey in the health technology sector [7].